Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors.

Graves' disease (GD) is a chronic autoimmune process in the thyroid gland and involves IFN and IFN driven immune activation. Assuming the thyroid gland is the main site stimulating the autoimmune response, we investigated the role of IFNs and other factors in the chronic evolution of GD by comparing the transcriptomic profiles of thyroid glands from short clinical course (SC), long clinical course (LC) cases, and control glands (C). Over 200 differentially expressed genes of the immune system were identified. Results were extensively analyzed bioinformatically and validated by qPCR in 31 glands. The analysis indicated that GD involved a progressive accumulation of changes with clearly distinct profiles in the SC and LC glands. Humoral response, antigen presentation and chemokines & cytokines were overall the most represented gene ontology categories in LC cases. Ingenuity Pathway Analysis pointed to a few inflammatory pathways in SC cases whereas LC cases involved numerous complex pathways, such us "communication between innate and adaptive immune cells" and "autoimmune thyroid signaling". A broad IFN signature consisted of the over-expression of 74 and 84 type I and type II IFN responsive genes respectively (overall 96 out of 211, 45%), but many of these genes can also be directly activated through cytoplasmic viral receptors. For the first time, plasmocytoid dendritic cells were identified in GD thyroid, but surprisingly, the main producers of IFN-alpha were cells with a myeloid cell phenotype. In addition, cells with the phenotype of alternatively activated macrophages were detected in abundance in GD thyroids, confirming data from the transcriptomic analysis. Collectively, these results confirmed the role of IFNs, suggested other natural immunity triggers, identified new cell types in the local disease process, and expanded our knowledge of the processes that may determine the chronicity of GD.

[1]  I. Todd,et al.  Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. , 1988, The Journal of clinical endocrinology and metabolism.

[2]  P. Unger,et al.  Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration. , 1994, The Journal of clinical endocrinology and metabolism.

[3]  G. Köhler,et al.  Conventional Bone Marrow-Derived Dendritic Cells Contribute to Toll-Like Receptor-Independent Production of Alpha/Beta Interferon in Response to Inactivated Parapoxvirus Ovis , 2009, Journal of Virology.

[4]  A. Becker,et al.  Immunohistochemical Detection of Interferon-γ: Fake or Fact? , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  R. Silverman,et al.  Small self-RNA generated by RNase L amplifies antiviral innate immunity , 2007, Nature.

[6]  A. Weetman,et al.  Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells. , 1989, The Journal of endocrinology.

[7]  E. Jacobson,et al.  The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. , 2008, Journal of autoimmunity.

[8]  R. Planas,et al.  Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long‐standing diabetes , 2010, Clinical and experimental immunology.

[9]  M. Juan,et al.  Chemokines Determine Local Lymphoneogenesis and a Reduction of Circulating CXCR4+ T and CCR7 B and T Lymphocytes in Thyroid Autoimmune Diseases1 , 2003, The Journal of Immunology.

[10]  A. Dayan,et al.  BIRTH CONTROL FOR PROBLEM PARENTS. , 1964, Lancet.

[11]  D. Clayton,et al.  A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region , 2006, Nature Genetics.

[12]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[13]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[14]  Rajni B. Sharma,et al.  Animal models for autoimmune myocarditis and autoimmune thyroiditis. , 2004, Methods in molecular medicine.

[15]  D. Olive,et al.  Costimulatory Molecules and Autoimmune Thyroid Diseases , 2002, Autoimmunity.

[16]  M. Juan,et al.  Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. , 2001, The American journal of pathology.

[17]  A. Thomson,et al.  Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig. , 1985, Clinical and experimental immunology.

[18]  Terry J. Smith,et al.  Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. , 2006, Endocrinology.

[19]  R. Mariuzza,et al.  Cis interactions of immunoreceptors with MHC and non-MHC ligands , 2008, Nature Reviews Immunology.

[20]  G. Daniels,et al.  Chronic autoimmune thyroiditis. , 1996, The New England journal of medicine.

[21]  Christophe Benoist,et al.  A Plaidoyer for ‘Systems Immunology’ , 2006, Immunological reviews.

[22]  M. Todaro,et al.  Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis , 1997, Science.

[23]  M. Landini,et al.  Human cytomegalovirus targets different subsets of antigen‐presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity , 2009, Reviews in medical virology.

[24]  L. Chiovato,et al.  Lectin-induced expression of DR antigen on human cultured follicular thyroid cells , 1983, Nature.

[25]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[26]  A. Belfiore,et al.  Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells. , 1992, Journal of autoimmunity.

[27]  G. Ning,et al.  Expression of IFNα-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves’ disease , 2010, Molecular and Cellular Endocrinology.

[28]  M. Kurrer,et al.  VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. , 2006, The Journal of clinical investigation.

[29]  R A Irizarry,et al.  On the utility of pooling biological samples in microarray experiments. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Braverman,et al.  Comprar Werner & Ingbar's The Thyroid, A FUNDAMENTAL AND CLINICAL TEXT | David K.C. Cooper | 9781451120639 | Lippincott Williams & Wilkins , 2012 .

[31]  F. Aloisi,et al.  Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.

[32]  M. Feldmann,et al.  ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY , 1983, The Lancet.

[33]  Y. Tomer.  Hepatitis C and interferon induced thyroiditis. , 2010, Journal of autoimmunity.

[34]  P. Laurberg,et al.  Interferon-alpha and autoimmune thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.

[35]  M. Sospedra,et al.  Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells: Induction by cytokines and over expression in autoimmune glands , 1994, Clinical and experimental immunology.

[36]  G. Dworacki,et al.  Expression of CD56 (NKH‐1) differentiation antigen in human thyroid epithelium , 1992, Clinical and experimental immunology.

[37]  M. Sospedra,et al.  HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. , 1999, International immunology.

[38]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[39]  H. Cordell,et al.  Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. , 2007, The Journal of clinical endocrinology and metabolism.

[40]  X. Zhang,et al.  Macrophage activation by endogenous danger signals , 2008, The Journal of pathology.

[41]  R. Pujol-Borrell,et al.  Influx of recent thymic emigrants into autoimmune thyroid disease glands in humans , 2008, Clinical and experimental immunology.

[42]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[43]  D. Čiháková,et al.  Alternatively activated macrophages in infection and autoimmunity. , 2009, Journal of autoimmunity.

[44]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[45]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[46]  E. Kaplan,et al.  Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases? , 1995, The Journal of clinical endocrinology and metabolism.

[47]  D. Munn,et al.  The Countervailing Actions of Myeloid and Plasmacytoid Dendritic Cells Control Autoimmune Diabetes in the Nonobese Diabetic Mouse1 , 2007, The Journal of Immunology.

[48]  D. Doniach,et al.  ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY , 1983, The Lancet.

[49]  M. Crow,et al.  Activation of the type I interferon pathway in primary Sjogren's syndrome. , 2010, Journal of autoimmunity.

[50]  I. Frazer.  Autoimmunity and persistent viral infection: two sides of the same coin? , 2008, Journal of autoimmunity.

[51]  P. Rosenstiel,et al.  The Nucleotide-Binding Oligomerization Domain-Like Receptor NLRC5 Is Involved in IFN-Dependent Antiviral Immune Responses , 2010, The Journal of Immunology.

[52]  S. Moestrup,et al.  CD163: a regulated hemoglobin scavenger receptor with a role in the anti‐inflammatory response , 2004, Annals of medicine.

[53]  Yang Liu,et al.  CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses , 2009, Science.

[54]  G. Ning,et al.  Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease. , 2008, Clinical immunology.

[55]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[56]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[57]  M. Raaben,et al.  Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo , 2009, BMC Genomics.

[58]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[59]  L. Braverman,et al.  Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text , 1991 .

[60]  M. Gilliet,et al.  Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2008, Nature Reviews Immunology.

[61]  R. Tampé,et al.  Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity. , 1997, Tissue antigens.

[62]  J. Di Domizio,et al.  TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. , 2009, Blood.

[63]  D. Hober,et al.  Viruses and thyroiditis: an update , 2009, Virology Journal.

[64]  M. Feldmann,et al.  Interferon-gamma induces HLA-DR expression by thyroid epithelium. , 1985, Clinical and experimental immunology.

[65]  P. Marrack,et al.  Terminating the immune response , 2010, Immunological reviews.